Effects of Ginsenosides on Drug-Metabolizing Enzymes
Author Information
Author(s): Hao Miao, Zhao Yuqing, Chen Peizhan, Huang He, Liu Hong, Jiang Hualiang, Zhang Ruiwen, Wang Hui
Primary Institution: Key Laboratory of Nutrition and Metabolism, Institute for Nutritional Sciences, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences
Hypothesis
Investigating the effects of ginsenosides on P450 enzymes will help elucidate the mechanism of ginseng-drug interactions.
Conclusion
The study found that ginsenosides have varying inhibitory effects on drug-metabolizing P450 enzymes, which may explain inconsistencies in previous reports of ginseng-drug interactions.
Supporting Evidence
- Ginsenosides showed varying inhibitory effects on CYP1A2, CYP2C9, CYP2C19, CYP2D6, and CYP3A4 enzymes.
- Substrate-dependent effects were observed in the inhibition profiles of ginsenosides on CYP3A4.
- A pharmacophore model was established to explain the structure-activity relationships of ginsenosides on P450 enzymes.
- Previous studies reported inconsistent effects of ginsenosides on P450 enzymes, which this study aimed to clarify.
Takeaway
Ginsenosides, which are compounds found in ginseng, can change how certain drugs are processed in the body, and this can be different depending on the type of ginsenoside used.
Methodology
The study evaluated the inhibitory effects of fifteen ginsenosides and sapogenins on five major human drug-metabolizing P450 enzymes using fluorescent probes.
Limitations
The study's findings may not fully translate to in vivo situations due to the complexity of human metabolism and the limited pharmacokinetic data available for ginsenosides.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website